betahistin actavis 8mg tableta
actavis group ptc ehf., hafnarfjördur array - 3444 betahistin-dihydrochlorid - tableta - 8mg - betahistin
donepezil actavis 10mg potahovaná tableta
actavis group ptc ehf., hafnarfjördur array - 17598 monohydrÁt donepezil-hydrochloridu - potahovaná tableta - 10mg - donepezil
donepezil actavis 5mg potahovaná tableta
actavis group ptc ehf., hafnarfjördur array - 17598 monohydrÁt donepezil-hydrochloridu - potahovaná tableta - 5mg - donepezil
gliklazid actavis 30mg tableta s řízeným uvolňováním
actavis group ptc ehf., hafnarfjördur array - 4622 gliklazid - tableta s řízeným uvolňováním - 30mg - gliklazid
gliklazid actavis 60mg tableta s řízeným uvolňováním
actavis group ptc ehf., hafnarfjördur array - 4622 gliklazid - tableta s řízeným uvolňováním - 60mg - gliklazid
sumatriptan actavis 50mg obalená tableta
actavis group ptc ehf., hafnarfjördur array - 10645 sumatriptan-sukcinÁt - obalená tableta - 50mg - sumatriptan
aubagio
sanofi winthrop industrie - teriflunomid - roztroušená skleróza - selektivní imunosupresiva - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
tecfidera
biogen netherlands b.v. - dimethyl fumarát - roztroušená skleróza - imunosupresiva - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
fampridine accord
accord healthcare s.l.u. - fampridin - roztroušená skleróza - další léky na nervový systém - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).
kesimpta
novartis ireland ltd - ofatumumab - roztroušená skleróza, relaps-remitentní - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.